Sponsored by
|
|
|
|
By Helen Branswell
JOHN WESSELS/AFP/Getty Images
Though cases were detected in Uganda this week, they were spotted and isolated quickly and as yet, there is no evidence of transmission in a second country.
Read More
|
By Lev Facher
Adobe
Amgen, Merck, Eli Lilly, and the Association of National Advertisers sued the Trump administration over a new policy to require drug prices in TV ads.
Read More
|
By Maggie Fox
Cynthia S. Goldsmith, Yiting Zhang/CDC
The researchers hope their work will lead to a test for the condition, called acute flaccid myelitis, which has been diagnosed in more than 500 kids.
Read More
|
Sponsor content by INTRA-CELLULAR THERAPIES
The diverse nature of schizophrenia presents critical unmet needs
More than 80 percent of patients with schizophrenia will relapse within five years after a single episode and often fail to recover to the same functional level. Currently available treatments often come with side effects that impact the lives of people living with the disease like Ariella, Lance, and Israel — an artist, a gamer, and a student.
Learn more about how schizophrenia derails peoples’ lives here.
|
By Adam Feuerstein
Ruby Wallau for STAT
Zynteglo, the one-and-done gene therapy for beta thalassemia newly approved in Europe, will carry a price tag of $1.8 million, Bluebird announced.
Read More
|
By Rebecca Robbins and Adam Feuerstein and Damian Garde
Courtesy Josiah Zayner
Josiah Zayner explains what it's like to be investigated by California officials for his version of do-it-yourself science — and self-experimentation.
Read More
|
|